Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

March 31, 2011

Conditions
Superficial Bladder Cancer
Interventions
PROCEDURE

Whole bladder laser light treatment as an alternative to radical cystectomy

The drug,Photofrin,at the dose of 1.5 mg/kg is infused intravenously two days prior to performing whole bladder laser light (630 nm) treatment.

DRUG

Photofrin

The drug,Photofrin,at the dose of 1.5 mg/kg is infused intravenously two days prior to performing whole bladder laser light (630 nm) treatment.

Trial Locations (1)

32608

Malcom Randall NF/SG Veterans Administration Health System, Gainesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

North Florida Foundation for Research and Education

OTHER

collaborator

Axcan Pharma

INDUSTRY

lead

North Florida/South Georgia Veterans Health System

OTHER

NCT00322699 - Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer | Biotech Hunter | Biotech Hunter